Phase Ii Study Of Paclitaxel Given Once Per Week Along With Trastuzumab And Pertuzumab In Patients With Human Epidermal Growth Factor Receptor 2 Positive Metastatic Breast Cancer (Vol 33, Pg 442, 2015)
JOURNAL OF CLINICAL ONCOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要